Special Issue "Vasculitis in Adults and Children: Symptoms, Diagnosis and Treatment"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Vascular Medicine".

Deadline for manuscript submissions: 15 September 2023 | Viewed by 70

Special Issue Editor

Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan
Interests: vasculitis; rheumatoid arthritis; giant cell arteritis; Takayasu arteritis; ANCA-associated vasculitis

Special Issue Information

Dear Colleagues,

Vasculitis is classified into large-vessel, medium-vessel, and small-vessel vasculitis according to the size of the affected arteries, and causes serious organ damage through ischemia, infarction, bleeding, dissection, and aneurysm formation. Treatment previously relied on high-dose glucocorticoids and cyclophosphamide, regardless of the size of the affected arteries, with substantial side effects; however, in recent years molecularly targeted therapeutic agents, such as tocilizumab, rituximab, mepolizumab, and avacopan, have enabled remission to be effectively induced and/or maintained, and have also reduced the total amount of glucocorticoids required for the corresponding vasculitis. This Special Issue, “Vasculitis in Adults and Children: Symptoms, Diagnosis and Treatment”, summarizes recent topics on the symptoms, diagnosis, and treatment of vasculitis in both adults and children. Clinical research regarding epidemiology, gender difference, prognostic factors, complications, classification criteria, and treatment, but also basic/translational research which tries to identify novel therapeutic targets, are welcomed. In this way, we should be able to better understand how to diagnose, and how to treat, vasculitis. We also discuss how future therapeutic strategies resolve the current unmet medical needs. Thus, authors are encouraged to submit original research, review articles, systematic reviews, and meta-analyses.

Dr. Ryu Watanabe
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • vasculitis
  • glucocorticoids
  • cyclophosphamide
  • molecularly targeted therapy
  • unmet clinical needs
  • potential therapeutic targets

Published Papers

This special issue is now open for submission.
Back to TopTop